Compare HLMN & MYGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HLMN | MYGN |
|---|---|---|
| Founded | 1964 | 1991 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 481.6M |
| IPO Year | 2020 | 1996 |
| Metric | HLMN | MYGN |
|---|---|---|
| Price | $8.13 | $4.59 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 8 |
| Target Price | ★ $11.60 | $7.64 |
| AVG Volume (30 Days) | ★ 2.0M | 1.6M |
| Earning Date | 05-22-2026 | 05-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 122.22 | N/A |
| EPS | ★ 0.20 | N/A |
| Revenue | ★ $1,552,224,000.00 | $771,400,000.00 |
| Revenue This Year | $7.65 | $7.19 |
| Revenue Next Year | $4.79 | $5.64 |
| P/E Ratio | $40.28 | ★ N/A |
| Revenue Growth | ★ 5.41 | 2.33 |
| 52 Week Low | $6.63 | $3.76 |
| 52 Week High | $10.85 | $10.30 |
| Indicator | HLMN | MYGN |
|---|---|---|
| Relative Strength Index (RSI) | 36.10 | 40.01 |
| Support Level | $7.91 | $3.93 |
| Resistance Level | $8.32 | $5.63 |
| Average True Range (ATR) | 0.25 | 0.34 |
| MACD | 0.00 | 0.02 |
| Stochastic Oscillator | 27.22 | 16.43 |
Hillman Solutions Corp is a provider of hardware-related products and related merchandising services to retail markets in North America. The company sells its products to hardware stores, home centers, mass merchants, pet supply stores, and other retail outlets. Its product lines include thousands of small parts such as fasteners and related hardware items; threaded rod and metal shapes; keys and accessories; builder's hardware; personal protective equipment, such as gloves and eye-wear; and identification items, such as tags and letters, numbers, and signs. The segments of the company are Hardware and Protective Solutions, which is the key revenue-generating segment; Robotics and Digital Solutions; and Canada. It has a business presence in the U.S, Canada and Mexico.
Myriad Genetics Inc is a molecular diagnostics and precision medicine company committed to advancing health and well-being for all. The company develops and commercializes molecular tests that help patients and providers uncover genetic insights. Its tests assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties, supporting earlier detection, more precise treatment, and lowering healthcare costs. Its tests include BRACAnalysis CDx, EndoPredict, FirstGene, Foresight, GeneSight, MyChoice CDx, MyRisk (cancer treatment), MyRisk (cancer risk), Prequel, Precise Tumor, Prolaris, and SneakPeek. The company operates in the US and Rest of World, with maximum revenue from the US.